Skip to Main Content

Paper Details

Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease.
Gastroenterology
3
2023
Adalimumab, Crohn's Disease, Patients
Author NameAffiliation
Marla C DubinskyIcahn School of Medicine at Mount Sinai
  • 1 - 1

Datasets

Release 1.2